Literature DB >> 1396810

Cardiac involvement in thalassaemia major: altered atrial natriuretic peptide levels in asymptomatic patients.

G Derchi1, P Bellone, G L Forni, G Lupi, S Jappelli, M Randazzo, V Zino, C Vecchio.   

Abstract

Congestive heart failure is the most common cause of death in young adults with thalassaemia major. In the present study we compared atrial natriuretic peptide levels (ANP) in 30 asymptomatic patients with thalassaemia major (aged 16.6 +/- 6.4 years), normal left ventricular diastolic cavity dimension and systolic function, with 30 aged and sex matched normal control subjects. ANP levels were significantly higher in patients with thalassaemia major compared to controls (93.9 +/- 26.3 pg.ml-1 vs 51.8 +/- 26.5 pg.ml-1; P < 0.001). Plasmatic renin activity, aldosterone, urinary sodium and catecholamine levels at basal conditions did not differ significantly in these two groups (ns). Blood volume stimulation (blood transfusion) in thalassaemic patients was followed by an increase of mean ANP values (93.9 +/- 26.3 to 109.1 +/- 40.5 pg.ml-1; P < 0.03). ANP basal levels above two standard deviations of the mean values obtained in normal control subjects were considered as abnormal and found to be in close correlation with the presence of diastolic dysfunction of the left ventricle identified by Doppler echocardiography. The method has a 57% sensitivity and a 91% specificity for revealing pre-clinical cardiac involvement (P < 0.02). Although a longer observation period is necessary in order to define the clinical and prognostic significance of these data, our results show that an increase in ANP basal values is present in asymptomatic patients with thalassaemia major. This suggests initial myocardial involvement, while ANP response to volume overload is maintained.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396810     DOI: 10.1093/oxfordjournals.eurheartj.a060068

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

1.  The effect of iron overload in the hearts of patients with beta-thalassemia.

Authors:  S V Brili; A I Tzonou; S S Castelanos; C J Aggeli; C A Tentolouris; C E Pitsavos; P K Toutouzas
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

2.  Early detection of myocardial dysfunction in children with beta-thalassaemia major.

Authors:  Tayfun Uçar; Talia Ileri; Semra Atalay; Zümrüt Uysal; Ercan Tutar; Mehmet Ertem
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-24       Impact factor: 2.357

Review 3.  Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity.

Authors:  Suree Lekawanvijit; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

Review 4.  Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review.

Authors:  M Mamtani; H Kulkarni
Journal:  Osteoporos Int       Date:  2009-02-26       Impact factor: 4.507

5.  Quantitative analysis of left atrial function in asymptomatic patients with b-thalassemia major using real-time three-dimensional echocardiography.

Authors:  Constantina Aggeli; Ioannis Felekos; Emmanuel Poulidakis; Athanasios Aggelis; Dimitrios Tousoulis; Christodoulos Stefanadis
Journal:  Cardiovasc Ultrasound       Date:  2011-11-24       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.